Pages that link to "Q34322087"
Jump to navigation
Jump to search
The following pages link to Histone modification enzymes: novel targets for cancer drugs (Q34322087):
Displaying 29 items.
- Toxoplasma histone acetylation remodelers as novel drug targets (Q22305931) (← links)
- Temporal and epigenetic regulation of neurodevelopmental plasticity. (Q33274777) (← links)
- Chromatin-mediated epigenetic regulation in the malaria parasite Plasmodium falciparum (Q34055162) (← links)
- Functional modulation of IGF-binding protein-3 expression in melanoma (Q34505279) (← links)
- Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases (Q34795203) (← links)
- Regulation of immune responses by histone deacetylase inhibitors (Q35855571) (← links)
- Drug discovery strategies: technologies to accelerate translation from target to drug (Q36028608) (← links)
- Drug discovery from natural products (Q36424053) (← links)
- Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts (Q36528232) (← links)
- The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression (Q36697766) (← links)
- Inhibitors of the heat shock response: biology and pharmacology (Q36845355) (← links)
- BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer (Q37148045) (← links)
- Differential cellular and molecular effects of butyrate and trichostatin a on vascular smooth muscle cells (Q37277291) (← links)
- Endosomal disruptors in non-viral gene delivery (Q37702252) (← links)
- Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs (Q37878207) (← links)
- Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives. (Q38031633) (← links)
- Microbial natural products: molecular blueprints for antitumor drugs. (Q38133765) (← links)
- Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer (Q38272302) (← links)
- The predictive value of ERCC1 and p53 for the effect of panobinostat and cisplatin combination treatment in NSCLC. (Q38878715) (← links)
- HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells. (Q39525805) (← links)
- Experimental study on inhibitory effects of histone deacetylase inhibitor MS-275 and TSA on bladder cancer cells (Q39889318) (← links)
- TMZ-BioShuttle--a reformulated temozolomide (Q39939002) (← links)
- Immunohistochemical analysis of acetylation, proliferation, mitosis, and apoptosis in tumor xenografts following administration of a histone deacetylase inhibitor--a pilot study (Q40334140) (← links)
- Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts (Q45870370) (← links)
- Gene expression studies demonstrate that the K-ras/Erk MAP kinase signal transduction pathway and other novel pathways contribute to the pathogenesis of cumene-induced lung tumors (Q46468224) (← links)
- Lipopolysaccharide modulates p300 and Sirt1 to promote PRMT1 stability via an SCFFbxl17-recognized acetyldegron. (Q47837957) (← links)
- DeepHistone: a deep learning approach to predicting histone modifications (Q64075203) (← links)
- Allosteric regulation of protein 14-3-3ζ scaffold by small-molecule editing modulates histone H3 post-translational modifications (Q92424151) (← links)
- Modifications of histones in parasites as drug targets (Q92919048) (← links)